Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen

被引：0
|
作者：
Yukiko Onishi
Hitoshi Ishii
Tomonori Oura
Masakazu Takeuchi
机构：
[1] The Institute for Adult Diseases,Department of Diabetology
[2] Asahi Life Foundation,undefined
[3] Nara Medical University,undefined
[4] Eli Lilly Japan K.K.,undefined
[5] Medical Development Unit—Japan,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Dulaglutide; Glycemic control; GLP-1 analog; Hypoglycemia; Insulin therapy; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：735 / 745
页数：10
相关论文
共 50 条
  • [21] The efficacy and safety of once-weekly, subcutaneous dulaglutide monotherapy compared to glimepiride in Asian patients with type 2 diabetes mellitus
    Wang, W.
    Huang, C. -N.
    Young, M. -C.
    Li, P.
    Gu, L.
    Yang, J.
    DIABETOLOGIA, 2015, 58 : S375 - S375
  • [22] Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
    Arslanian, Silva A.
    Hannon, Tamara
    Zeitler, Philip
    Chao, Lily C.
    Boucher-Berry, Claudia
    Barrientos-Perez, Margarita
    Bismuth, Elise
    Dib, Sergio
    Cho, Jang Ik
    Cox, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (05): : 433 - 443
  • [23] Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study
    Ishii, Hitoshi
    Onishi, Yukiko
    Oura, Tomonori
    Takeuchi, Masakazu
    DIABETES THERAPY, 2020, 11 (01) : 133 - 145
  • [24] Once-Weekly Dulaglutide for Treatment of Youths with Type 2 Diabetes
    Senoo, Yuki
    Kami, Masahiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1529 - 1530
  • [25] Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6
    Russell-Jones, D.
    Babazono, T.
    Cailleteau, R.
    Engberg, S.
    Irace, C.
    Kjaersgaard, M. I. S.
    Mathieu, C.
    Rosenstock, J.
    Woo, V.
    Klonoff, D. C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S8
  • [26] Efficacy and safety of once-weekly insulin versus once-daily insulin in patients with type 1 and type 2 diabetes mellitus: an updated meta-analysis of randomized controlled trials
    Xue, Mei
    Shen, Pan
    Tang, Jun
    Deng, Xuan
    Dai, Zhe
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [27] Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment REPLY
    Rosenstock, Julio
    Hansen, Melissa V.
    Goldenberg, Ronald
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (08):
  • [28] Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
    Hovelmann, Ulrike
    Brondsted, Lise
    Kristensen, Niels R.
    Ribel-Madsen, Rasmus
    Devries, J. Hans
    Heise, Tim
    Haahr, Hanne
    DIABETES, 2020, 69
  • [29] Insulin icodec: an insulin analogue suited for once-weekly dosing in type 2 diabetes
    Hovelmann, U.
    Brondsted, L.
    Kristensen, N. R.
    Ribel-Madsen, R.
    DeVries, J. H.
    Heise, T.
    Haahr, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S316 - S316
  • [30] Efficacy and safety of once weekly dulaglutide vs insulin glargine in combination with metformin and glimepiride in type 2 diabetes patients (AWARD-2)
    Giorgino, F.
    Benroubi, M.
    Sun, J. -H.
    Zimmermann, A. G.
    Pechtner, V.
    DIABETOLOGIA, 2014, 57 : S22 - S22
12345